Improving companies’ access to Flemingsberg’s research infrastructure

Work continues to strengthen collaboration between small and medium-sized enterprises and the research infrastructures in Flemingsberg. Flemingsberg Science leads this project together with Karolinska Institutet and the Center for Innovative Medicine (CIMED).

Campus Flemingsberg has approximately 20 research infrastructures that support high-tech basic research and conventional research. Cutting-edge expertise in areas such as imaging, bioinformatics, cell therapy and movement analysis is included. More of these research infrastructures will now also be able to offer their services to small and medium-sized companies.

“Our research infrastructures are a key part of Campus Flemingsberg. Now we want to give more infrastructures the opportunity to collaborate with companies in the Life Science sector,” says Johnny Högberg, CEO Flemingsberg Science.

Following up Stockholm Life Tech
In a new project, Flemingsberg Science is collaborating with Karolinska Institutet and CIMED. The project follows up on the experiences of the Stockholm Life Tech project, which identified considerable potential to strengthen research infrastructures and companies on Campus Flemingsberg. Within the framework of Stockholm Life Tech, among other things, a guide was developed that functions as a support through the entire process from preparation, development to execution.

“The methodology that was developed can be used to improve how the infrastructures function, for example by providing them with a broader basis for their funding. We aim to add one or two research infrastructures a year to 2025,” says Högberg.

CIMED is a regional research fund tasked with stimulating research and enriching the research environment at Campus Flemingsberg.

“The presence of different kinds of companies, including startups, enriches and develops the campus environment. Strong collaboration between companies, universities and healthcare is crucial for us to further improve the research environment,” explains Annika Bergquist, Director CIMED.

The project is planned to continue until 2025 and will be evaluated annually.
“We always work with smaller pilot projects, “test balloons” as they’re called, and can provide temporary stimulus funds. If the project works well, the plan is to continue to develop it without support,” says Bergquist.

It’s official – Alfa Laval has opened its new premises in Flemingsberg!

The new 8,000 m² innovation center brings together 700 experts who push the boundaries of future solutions in energy, food, pharma and marine transport every day. An investment that truly shows how important Swedish industrial expertise, open collaborations and continued R&D are – not only for Alfa Laval, but for the whole of Europe.

50 years of life-changing therapies

On November 12 1975, the first allogeneic bone marrrow transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.

The Royal Opera and Idun Lovén Art School Create Art in Flemingsberg

In Flemingsberg, education, art, and culture come together in a unique way. Now, the Royal Opera and Idun Lovén Art School are launching a collaboration where students will work side by side with professional set painters to create a backdrop painting that will adorn the opera’s foyer in Scenhuset in Flemingsberg.